Dosidal · Switzerland

Benlysta, Pulver zur Herstellung einer Infusionslösung

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:61532 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 61532
atc: L04AG04
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 2012-06-14
term: zugelassen
valid_until: 9999-12-31
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: L04AG04
authorisation_number: 61532
form: PULPA
holder: GlaxoSmithKline AG
holder_partner_nr: 1000930
it_number: 07.15.0.
name: Benlysta, Pulver zur Herstellung einer Infusionslösung
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
iuUm5m63hly5Nm0JiTH0HUswN2N6RJ7xOVTIwzs9jJIEQsk4C6gRjRftiUUPtp5nNYaiTPNqnmjvvryreUcRSg
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/ch:authorisation:61532 · Related records in other markets · Dosidal